Jeffrey Dierks, CHIEF COMMERCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 21,014 shares at $37.01 ($778K) on 2025-01-15, disclosed to the SEC on 2025-01-16.
Scheduled sale ($778k) by CHIEF COMMERCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.01 | 10,507 | $389K | 50.0% |
| 2 | $37.01 | 10,507 | $389K | 50.0% |
| Total | $37.01 avg | 21,014 | $778K | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |
| HRMY | SELL | 2024-10-31 | $1.7M | — | Filing → |